REHOVOT, Israel and BRIDGEWATER, N.J., June 18, 2014 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals (the "Company"), a clinical stage specialty pharmaceutical company focused on the development, patenting and commercialization of proprietary topical foams to address unmet needs in dermatology, today announced that Dov Tamarkin Ph.D., CEO, will present an update on the Company and its pipeline at the BIO International Convention (BIO 2014) on Thursday, June 26th in San Diego, CA.
Help employers find you! Check out all the jobs and post your resume.
